Rani Therapeutics (NasdaqGM:RANI) Q4 2025 Earnings call March 26, 2026 04:30 PM ET Company ParticipantsStephen Jasper - Managing DirectorSvai Sanford - CFOTalat Imran - CEOConference Call ParticipantsBrandon Folkes - Senior Research AnalystMichael Okunewitch - Senior Research AnalystOperatorWelcome to the Rani fourth quarter and full year 2025 financial results and corporate update conference call. At this time, all participants are on a listen-only mode. Following management's prepared remarks, Rani will h ...